3.1299
-0.2201 (-6.57%)
-0.2201 (-6.57%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.2201 | -6.57% | 3.1299 | 19:46:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.30 | 3.10 | 3.32 | 3.17 | 3.35 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.11 | 3.13 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 791 | 127,174 | $ 3.21 | $ 408,266 | 1,428,459 | 1.08 - 7.05 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:46:50 | formt | 1,000 | $ 3.1299 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 43.56M | 13.92M | 9.12M | $ - | $ - | -2.91 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.74 | 3.79 | 2.90 | 3.33 | 186,203 | -0.6101 | -16.31% |
| 1 Month | 3.64 | 4.59 | 2.90 | 3.80 | 377,283 | -0.5101 | -14.01% |
| 3 Months | 2.69 | 4.78 | 2.30 | 3.63 | 928,342 | 0.4399 | 16.35% |
| 6 Months | 2.75 | 4.78 | 2.15 | 3.49 | 483,553 | 0.3799 | 13.81% |
| 1 Year | 4.75 | 7.05 | 1.08 | 3.59 | 385,429 | -1.62 | -34.11% |
| 3 Years | 17.64 | 34.10 | 1.08 | 5.33 | 183,568 | -14.51 | -82.26% |
| 5 Years | 8.55 | 34.10 | 1.08 | 5.57 | 164,567 | -5.42 | -63.39% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
